<ARTICLE> 5 <LEGEND> THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM HOUSTON BIOTECHNOLOGY INCORPORATED 10-Q DATED 6-30-96 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> JUN-30-1996 <CASH> 347,356 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 391,356 <PP&E> 365,988 <DEPRECIATION> 2,256,789 <TOTAL-ASSETS> 769,906 <CURRENT-LIABILITIES> 1,134,883 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 56,387 <OTHER-SE> (652,746) <TOTAL-LIABILITY-AND-EQUITY> 769,906 <SALES> 600,000 <TOTAL-REVENUES> 659,579 <CGS> 0 <TOTAL-COSTS> 1,126,822 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> 467,243 <INCOME-TAX> 0 <INCOME-CONTINUING> 467,243 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 467,243 <EPS-PRIMARY> (.08) <EPS-DILUTED> (.08)